Stocks
Spruce Biosciences, Inc.SPRB
NASDAQHealthcareBiotechnology$41.23
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for rare endocrine disorders, with its lead candidate targeting congenital adrenal hyperplasia. Investors track the stock for its pipeline progress and regulatory milestones in a niche therapeutic area.
52W Range: $38.06-$148.88
Congressional Interest in Spruce Biosciences, Inc. (SPRB)
No congressional trades have been disclosed for Spruce Biosciences, Inc. (SPRB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SPRB?
No congressional trades found for this stock.